Disclosures Let Keryx Escape Kidney Drug Stock Suit
A Massachusetts federal judge handed Keryx Biopharmaceuticals Inc. a win in a proposed shareholder class action on Monday, ruling that the sole remaining plaintiff bought his shares of the company after...To view the full article, register now.
Already a subscriber? Click here to view full article